True innovation or just later to market? German agency questions benefits of new drugs

12th July 2019 Uncategorised 0

When a new drug is approved, the developer usually trumpets its ability to fill an unmet medical need. But a German agency that evaluates new treatments disagrees, calling for an international reform of drug development and approval.

More: True innovation or just later to market? German agency questions benefits of new drugs
Source: fierce